25 year trader and investor of the markets. Founded and managed a high sharpe ratio HF that had peak assets > $300MM. Present day, I am a CTA managing a short-term diversified and highly risk managed program focused on currencies, ags, energy, metals, bonds and indices.
I enjoy the market, particularly special situation type stocks with asymmetrical return profiles.
I am a retired Registered Nurse interested in biotech and new technology.
I am the Delta Sigmoid (dumb sh__)
I have no idea why people "follow" me, as I know next to nothing, and what I do know is enough to be dangerous to myself and others, I am good at sticking foot in mouth, and sticking up for people, and once in a while I even amuse myself!
It's a good thing I don't manage my own portfolio, I have mad money to play penny stocks, more fun than gambling, but my penny stock picks suck too!
Good luck to all!
Now where's my drink? ;)
Founder of Disruptive Tech Research – a technology research and advisory firm serving the investment management community.
We provide registered investment professionals and qualified firms with independent, targeted research to support the generation of investment ideas.
We focus on patent-filing activity to identify the most promising disruptive technology trends early. Then, we employ an original, bottom-up fundamental research approach to uncover micro- and small-cap ideas that are underfollowed, underappreciated and undervalued.
Our mission is to provide clients with differentiated, actionable and thorough fundamental research at a cost effective price.
We’re 100% independent. That means absolutely no pay-to-play arrangements, no hidden agendas and no hype. Just solid research. And yes, we eat our own cooking.
I started my investment career at Morgan Stanley, where I helped direct over $1 billion in in institutional capital. After growing bored with the monotony of asset allocation studies, investment policy statements, manager searches and evaluations, and Retirement Plan Service Provider RFPs (among other things), I left and co-founded Wall Street Daily, which quickly became one of the web’s largest financial publishers with a daily circulation of more than 700,000 readers.
In 2014, I founded Disruptive Tech Research to pursue my investing passion, and fill the void in the market for high-quality, 100% independent research on disruptive technologies.
I have been fortunate to appear regularly on CNBC’s Closing Bell, as well as be mentioned in other media outlets, including in The Wall Street Journal, The New York Times, Morningstar and MarketWatch. I earned my MBA from the Crummer Graduate School of Business at Rollins College, which is also where I met my beautiful wife.
Pro Deo, Pro Familia, Pro Patria
I joined Seeking Alpha in February 2014 as editor of the biotech vertical. In addition to onboarding new contributors, my job is to make sure Seeking Alpha provides high-quality and comprehensive coverage of the biotechnology and health care sectors. I am always looking for new ideas, so please reach out if you're interested.